United Therapeutics (UTHR) News Today $417.57 +7.70 (+1.88%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$416.56 -1.01 (-0.24%) As of 09/19/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is United Therapeutics Up Today?Toggle Visibility of Why Is United Therapeutics Up Today?United Therapeutics (NASDAQ:UTHR) shares are trading higher today, lifted by upcoming clinical data review, although several insiders have continued to lighten their positions. Positive Sentiment: United Therapeutics will host a webcast on September 28 to review data from the successful TETON-2 pivotal study of nebulized Tyvaso® in idiopathic pulmonary fibrosis, potentially strengthening its IPF pipeline.United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis Negative Sentiment: Director Judy Olian sold 1,800 shares at an average price of $415.43 on September 19, trimming her stake by about 26%.Director’s Major Stock Sale at United Therapeutics! Negative Sentiment: CEO Martine Rothblatt sold 4,000 shares at an average price of $400.17 on September 17, reducing her holding by 96.9%.United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares Negative Sentiment: EVP Paul Mahon sold 11,000 shares at an average price of $406.17 on September 18, cutting his position by 23%.United Therapeutics (NASDAQ:UTHR) EVP Sells $4,467,870.00 in Stock Negative Sentiment: COO Michael Benkowitz sold 22,500 shares at an average price of $400.56 on September 15, in a transaction worth over $9 million.Michael Benkowitz Sells 22,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock Posted 1+ days agoAI Generated. May Contain Errors. UTHR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Wedge Capital Management L L P NC Has $27.54 Million Holdings in United Therapeutics Corporation $UTHRSeptember 21 at 9:37 AM | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells $4,467,870.00 in StockSeptember 21 at 4:23 AM | americanbankingnews.comPallas Capital Advisors LLC Has $527,000 Stock Holdings in United Therapeutics Corporation $UTHRSeptember 21 at 3:44 AM | marketbeat.comJudy Olian Sells 1,800 Shares of United Therapeutics (NASDAQ:UTHR) StockSeptember 20 at 5:46 PM | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Sold by Livforsakringsbolaget Skandia OmsesidigtSeptember 20 at 5:58 AM | marketbeat.comDirector’s Major Stock Sale at United Therapeutics!September 19 at 10:11 PM | tipranks.comUnited Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary FibrosisSeptember 19 at 6:47 PM | finance.yahoo.comUnited Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 SharesSeptember 19 at 5:31 PM | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) EVP Sells $4,467,870.00 in StockSeptember 19 at 5:31 PM | marketbeat.comUnited Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary FibrosisSeptember 19 at 8:01 AM | businesswire.comInsider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of StockSeptember 19 at 6:59 AM | insidertrades.comSignal Advisors Wealth LLC Invests $1.53 Million in United Therapeutics Corporation $UTHRSeptember 19 at 4:16 AM | marketbeat.comMichael Benkowitz Sells 22,500 Shares of United Therapeutics (NASDAQ:UTHR) StockSeptember 18 at 8:23 AM | marketbeat.comBalefire LLC Invests $376,000 in United Therapeutics Corporation $UTHRSeptember 18 at 4:11 AM | marketbeat.comLivforsakringsbolaget Skandia Omsesidigt Trims Holdings in United Therapeutics Corporation $UTHRSeptember 18 at 4:07 AM | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of StockSeptember 17, 2025 | insidertrades.comVoya Investment Management LLC Boosts Stock Position in United Therapeutics Corporation $UTHRSeptember 17, 2025 | marketbeat.comUnited Therapeutics management to meet with Cantor FitzgeraldSeptember 16, 2025 | msn.comLiquidia Corporation (LQDA): A Bull Case TheorySeptember 16, 2025 | uk.finance.yahoo.comSwedbank AB Decreases Stock Position in United Therapeutics Corporation $UTHRSeptember 15, 2025 | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Sold by Integrated Wealth Concepts LLCSeptember 15, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 25,289 Shares of United Therapeutics Corporation $UTHRSeptember 15, 2025 | marketbeat.comFY2025 EPS Estimates for UTHR Raised by Cantor FitzgeraldSeptember 14, 2025 | marketbeat.comInspire Investing LLC Sells 1,237 Shares of United Therapeutics Corporation $UTHRSeptember 14, 2025 | marketbeat.comUTHR FY2025 EPS Forecast Lifted by Cantor FitzgeraldSeptember 14, 2025 | americanbankingnews.comInsider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $1,588,920.00 in StockSeptember 13, 2025 | marketbeat.comFY2026 EPS Estimates for UTHR Increased by Cantor FitzgeraldSeptember 13, 2025 | marketbeat.comAcadian Asset Management LLC Acquires 169,010 Shares of United Therapeutics Corporation $UTHRSeptember 13, 2025 | marketbeat.comFred Alger Management LLC Makes New $256,000 Investment in United Therapeutics Corporation $UTHRSeptember 13, 2025 | marketbeat.comEquities Analysts Offer Predictions for UTHR FY2026 EarningsSeptember 13, 2025 | americanbankingnews.comUnited Therapeutics (NASDAQ:UTHR) Director Sells $280,203.00 in StockSeptember 12, 2025 | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 4,560 Shares of StockSeptember 12, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) COO Sells $1,961,050.00 in StockSeptember 12, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 8,000 SharesSeptember 12, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) COO Sells $4,520,538.75 in StockSeptember 12, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock PriceSeptember 12, 2025 | marketbeat.com21,112 Shares in United Therapeutics Corporation $UTHR Acquired by Capital Impact Advisors LLCSeptember 12, 2025 | marketbeat.comMartine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) StockSeptember 12, 2025 | insidertrades.comUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society CongressSeptember 12, 2025 | businesswire.comAshton Thomas Private Wealth LLC Has $1.44 Million Stock Position in United Therapeutics Corporation $UTHRSeptember 12, 2025 | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Bought by Jacobs Levy Equity Management Inc.September 12, 2025 | marketbeat.comUnited Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last WeekSeptember 12, 2025 | investors.comCantor Fitzgerald Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) StockSeptember 12, 2025 | americanbankingnews.comUnited Therapeutics (NASDAQ:UTHR) Director Sells $280,203.00 in StockSeptember 11, 2025 | insidertrades.comEmpowered Funds LLC Has $17.87 Million Holdings in United Therapeutics Corporation $UTHRSeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Has $500,000 Holdings in United Therapeutics Corporation $UTHRSeptember 11, 2025 | marketbeat.comUnited Services Automobile Association Buys New Position in United Therapeutics Corporation $UTHRSeptember 11, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Acquires Shares of 2,812 United Therapeutics Corporation $UTHRSeptember 11, 2025 | marketbeat.comUnited Therapeutics price target raised to $525 from $405 at Cantor FitzgeraldSeptember 10, 2025 | msn.comUnited Therapeutics Meets 80-Plus Relative Strength Rating BenchmarkSeptember 10, 2025 | msn.com Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼0.880.76▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼2722▲UTHR Articles Average Week Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for United Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ALNY News REGN News BIIB News INCY News NBIX News EXEL News BMRN News EXAS News IONS News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
